---
title: "Astrazeneca Pharma India Ltd (ASTRAZEN) — Share Price, Financials & Analysis"
symbol: "ASTRAZEN"
company: "Astrazeneca Pharma India Ltd"
canonical: "https://tapetide.com/stocks/ASTRAZEN"
isin: "INE203A01020"
nse_symbol: "ASTRAZEN"
bse_code: "506820"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 16925
generated_at: "2026-09-13T18:19:29.105Z"
---

# Astrazeneca Pharma India Ltd (ASTRAZEN)

Canonical page: https://tapetide.com/stocks/ASTRAZEN

## Company

- **NSE Symbol:** ASTRAZEN
- **BSE Code:** 506820
- **ISIN:** INE203A01020
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2001-05-04
- **CEO:** Ms. Bhavana Agrawal
- **Employees:** 600
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** astrazenecaindia.com

## About

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.[1]

## Latest Price

- **Price:** ₹6764.5
- **Change:** -96 (-1.4%)
- **Open:** ₹6880
- **Day High:** ₹6880
- **Day Low:** ₹6750
- **Previous Close:** ₹6860.5
- **Volume:** 3314
- **As Of:** 2026-09-11T10:01:36+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:49.655722Z.

- **Market Cap:** ₹16925 Cr
- **Classification:** Smallcap
- **P/E (reported):** 101.1
- **P/E (TTM):** 99.7
- **EPS (TTM):** ₹67.85
- **EPS (reported):** ₹52.4
- **Book Value:** ₹349.12
- **Price to Book:** 19.65
- **Dividend Yield:** 0.52%
- **ROE:** 21.49%
- **ROCE:** 25.48%
- **Debt to Equity:** 0.13
- **Revenue (yearly):** ₹2304.1 Cr
- **Net Income:** ₹187.5 Cr
- **EBITDA:** ₹290.5 Cr
- **52-Week High:** ₹9849.5
- **52-Week Low:** ₹6801
- **RSI (14):** 22.61

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 70.07 | 9% |
| growth | 81.26 | 9% |
| momentum | 15.85 | 12% |
| ownership | 53.81 | 24% |
| quality | 39.39 | 22% |
| valuation | 20.13 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has been maintaining a healthy dividend payout of 51.4%

### Weaknesses

- Stock is trading at 19.4 times its book value

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -123.16% | -154.32% | -115.02% |
| ebitda margin growth | -12.01% | -24.81% | -23.48% | 2.52% |
| net income growth | -15.59% | 62.06% | 15% | 16% |
| revenue growth | 18.37% | 31.15% | 31% | 23% |
| roce | — | 31.61% | -16.79% | 22.78% |
| roe | — | 43.08% | 19.73% | 78.34% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 311 | 306 | 383 | 388 | 408 | 440 | 480 | 526 | 559 | 612 | 579 | 683 |
| Expenses | 258 | 291 | 334 | 349 | 355 | 363 | 394 | 445 | 484 | 567 | 518 | 634 |
| Operating Profit | 53 | 15 | 49 | 38 | 53 | 77 | 86 | 81 | 75 | 45 | 61 | 49 |
| OPM % | 17 | 4.9 | 13 | 10 | 13 | 17 | 18 | 15 | 13 | 7 | 11 | 7 |
| Other Income | 25 | 10 | 9 | -49 | 8 | -26 | 10 | 11 | 1 | 7 | 5 | 9 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 9 | 9 | 18 | 17 | 3 | 4 | 6 | 5 |
| Profit before tax | 73 | 20 | 54 | -15 | 51 | 42 | 78 | 75 | 73 | 47 | 58 | 51 |
| Tax % | 29 | 23 | 27 | -22 | 25 | 27 | 26 | 25 | 26 | 30 | 23 | 25 |
| Net Profit | 52 | 16 | 39 | -12 | 38 | 31 | 58 | 56 | 54 | 33 | 45 | 38 |
| EPS in Rs | 20.95 | 6.32 | 15.79 | -4.72 | 15.37 | 12.34 | 23.3 | 22.33 | 21.69 | 13.04 | 17.95 | 15.17 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 571 | 728 | 832 | 814 | 806 | 1003 | 1296 | 1716 | 2276 | 2432 |
| Expenses | 525 | 657 | 711 | 678 | 719 | 838 | 1111 | 1462 | 2014 | 2202 |
| Operating Profit | 46 | 71 | 121 | 135 | 86 | 165 | 184 | 254 | 262 | 230 |
| OPM % | 8 | 10 | 15 | 17 | 11 | 16 | 14 | 15 | 12 | 9 |
| Other Income | 12 | 16 | 13 | 13 | 15 | -14 | 51 | -56 | 23 | 21 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 |
| Depreciation | 15 | 15 | 19 | 20 | 17 | 16 | 15 | 40 | 29 | 17 |
| Profit before tax | 44 | 73 | 114 | 127 | 83 | 134 | 220 | 156 | 252 | 228 |
| Tax % | 41 | 25 | 37 | 27 | 26 | 26 | 26 | 26 | 26 | — |
| Net Profit | 26 | 54 | 72 | 93 | 62 | 99 | 162 | 116 | 188 | 170 |
| EPS in Rs | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 | 64.6 | 46.3 | 75.01 | 67.85 |
| Dividend Payout % | 0 | 0 | 3 | 5 | 41 | 40 | 37 | 69 | 48 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 218 | 242 | 296 | 359 | 451 | 506 | 584 | 707 | 765 | 868 |
| Borrowings | 0 | 0 | 0 | 12 | 12 | 9 | 7 | 5 | 36 | 111 |
| Other Liabilities | 193 | 214 | 261 | 330 | 306 | 337 | 389 | 362 | 712 | 1006 |
| Total Liabilities | 415 | 461 | 562 | 706 | 775 | 857 | 985 | 1078 | 1518 | 1989 |
| Fixed Assets | 87 | 75 | 75 | 72 | 81 | 74 | 69 | 67 | 64 | 117 |
| CWIP | 5 | 4 | 7 | 24 | 4 | 2 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 324 | 382 | 480 | 611 | 690 | 780 | 915 | 1011 | 1454 | 1872 |
| Total Assets | 415 | 461 | 562 | 706 | 775 | 857 | 985 | 1078 | 1518 | 1989 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 38 | 9 | 55 | 87 | 105 | 101 | 58 | 28 | 65 | -15 |
| Cash from Investing Activity | 0 | -9 | 4 | -171 | 173 | 5 | 18 | 22 | 31 | 19 |
| Cash from Financing Activity | 0 | 0 | 0 | -6 | -9 | -9 | -24 | -44 | -66 | -92 |
| Net Cash Flow | 38 | -1 | 59 | -90 | 269 | 96 | 52 | 5 | 31 | -88 |
| Free Cash Flow | 33 | 3 | 37 | 74 | 99 | 94 | 53 | 18 | 64 | -18 |
| CFO/OP | 133 | 28 | 126 | 100 | 101 | 146 | 60 | 46 | 51 | 26 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 29 | 35 | 40 | 37 | 38 | 39 | 39 | 43 | 39 | 34 |
| Inventory Days | 121 | 229 | 186 | 197 | 198 | 164 | 193 | 140 | 208 | 272 |
| Days Payable | 184 | 257 | 266 | 251 | 221 | 223 | 231 | 121 | 173 | 207 |
| Cash Conversion Cycle | -34 | 7 | -39 | -17 | 15 | -20 | 1 | 62 | 74 | 99 |
| Working Capital Days | -36 | -8 | -14 | -16 | -17 | -34 | -18 | 20 | 22 | 50 |
| ROCE % | 15 | 19 | 27 | 34 | 30 | 16 | 31 | 31 | 33 | 29 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 2.69% | 2.66% | 2.74% | 2.79% | 2.9% | 2.93% | 2.89% | 3.03% | 2.74% | 2.71% | 2.78% | 2.68% |
| DIIs | 2.43% | 2.75% | 3.78% | 5.01% | 5.1% | 5.22% | 4.65% | 4.56% | 5.26% | 5.56% | 5.8% | 6.08% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 17.44% | 17.09% | 16.33% | 15% | 14.77% | 14.62% | 15.16% | 15.18% | 14.39% | 14.14% | 13.88% | 13.76% |
| Others | 2.44% | 2.49% | 2.15% | 2.2% | 2.23% | 2.24% | 2.31% | 2.23% | 2.61% | 2.59% | 2.55% | 2.48% |
| No. of Shareholders | 32380 | 29032 | 29418 | 27169 | 27615 | 27322 | 32466 | 34378 | 32914 | 31551 | 29007 | 29338 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 3 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 6884.9 | Sell |
| EMA (10) | 6925.48 | Sell |
| SMA (20) | 7116.55 | Sell |
| EMA (20) | 7128.76 | Sell |
| SMA (50) | 7700.31 | Sell |
| EMA (50) | 7560.59 | Sell |
| SMA (100) | 8078.69 | Sell |
| EMA (100) | 7905.36 | Sell |
| SMA (200) | 8364.04 | Sell |
| EMA (200) | 8183.75 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 20.17 | Buy |
| MACD (12,26,9) | -275.25 | Buy |
| Stochastic (14,3,3) | 7.1 | Buy |
| ADX (14) | 47.79 | Buy |
| Williams %R (14) | -97.24 | Buy |
| ATR (14) | 152.91 | Neutral |
| ROC (12) | -5.43 | Sell |
| Stoch RSI (14) | 50.6 | Neutral |
| UO (7,14,28) | 35.2 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033d9e48-2099-4d1a-955f-b4c93b19fbac.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca30a832-4569-4c45-bb6a-6ec79231ed3d.pdf) |
| 2026-08-24 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f29be45-2372-4894-9420-416a367a4573.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=295b1ed6-0772-425f-b9ec-ca993fd7c05a.pdf) |
| 2026-08-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e403fe6-4189-47b6-bfcb-097108b97b38.pdf) |
| 2026-08-12 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b23e5c34-fd15-4a8c-b87b-b419453d0832.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a900c647-04e5-4314-b876-19efb2ea25a2.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2af2b74-1f8e-4d8a-895b-0f3a6add3c0b.pdf) |
| 2026-08-08 | [Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37bdb5eb-c003-4833-adbf-02d86d5352a9.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2e689a7-586c-4214-b4e7-bfa7d2d22e62.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Outcome Of The Board Meeting Held On Monday August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b7a4a2e-199a-43d1-be1d-3fe5d33d9933.pdf) |
| 2026-05-26 | [Outcome Of The Board Meeting Held On Tuesday May 26 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6286849-8d82-4c64-9c25-3ea886c88602.pdf) |
| 2026-02-11 | [Outcome Of The Board Meeting Held On Wednesday February 11 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c12ed04e-e85b-4410-b25c-abb0ed976195.pdf) |
| 2025-11-07 | [Outcome Of The Board Meeting Held On Friday November 7 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d93ebb7e-7e4b-4670-81e7-a59ce5368816.pdf) |
| 2025-08-14 | [Outcome Of The Board Meeting Held On Thursday August 14 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48cf5f79-c911-46e4-9d72-4828940b3d02.pdf) |
| 2025-02-11 | [Outcome Of The Board Meeting Held On Tuesday February 11 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497a6e78-e729-4993-828e-4ce935acc5e5.pdf) |
| 2024-11-13 | [Outcome Of The Board Meeting Held On Wednesday, November 13, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae1be72d-43b2-45e5-b9c0-4d7ca1511174.pdf) |
| 2024-08-08 | [Outcome Of The Board Meeting Held On Thursday, August 8, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f338c2fc-b916-405f-996d-109cead7d259.pdf) |
| 2024-05-27 | [Outcome Of The Board Meeting Held On Monday, May 27, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5a744f-148f-454e-8a74-fc214d8e0396.pdf) |
| 2024-02-08 | [Outcome Of The Board Meeting Held On Thursday, February 8, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a66fbe35-d692-41bb-8bfc-7a112b101971.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 March 2026 - Received Rs.6,77,73,200 order to design and manufacture automation equipment; 90-day execution. | [General Updates 6 March 2026 - Received Rs.6,77,73,200 order to design and manufacture automation equipment; 90-day execution.](https://nsearchives.nseindia.com/corporate/TECHERA_06032026132903_TECHERA.pdf) |
| 4 March 2026 - TechEra Engineering (India) Limited has informed about bagging of orders. | [General Updates 4 March 2026 - TechEra Engineering (India) Limited has informed about bagging of orders.](https://nsearchives.nseindia.com/corporate/TECHERA_04032026151915_TechEra_Order_announcement.pdf) |
| 4 February 2026 - Received ₹2.83 crore one‑year contract from private defence entity for precision components and assemblies. | [General Updates 4 February 2026 - Received ₹2.83 crore one‑year contract from private defence entity for precision components and assemblies.](https://nsearchives.nseindia.com/corporate/TECHERA_04022026183301_TECHERA.pdf) |
| 31 Mar - AstraZeneca India appoints Dr. Shashank Srinivasan Medical Director Oncology; promotes Venkat Natarajan to Director Market Access, effective April 1, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Appointment Of Senior Management Personnel 31 Mar - AstraZeneca India appoints Dr. Shashank Srinivasan Medical Director Oncology; promotes Venkat Natarajan to Director Market Access, effective April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ac44ee1-56d3-4314-8d06-480e4194474f.pdf) |
| 30 January 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … | [Price movement 30 January 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …](https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=TECHERA&tabIndex=sme) |
| 29 Apr - Submitted Regulation 74(5) compliance certificate for March 2026 dematerialization processing. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 29 Apr - Submitted Regulation 74(5) compliance certificate for March 2026 dematerialization processing.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5cce4f82-8f30-436a-a4d2-80f1f543104b.pdf) |
| 29 Apr - Submitted Regulation 74(5) compliance certificate for March 2026 dematerialization processing. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 29 Apr - Submitted Regulation 74(5) compliance certificate for March 2026 dematerialization processing.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5cce4f82-8f30-436a-a4d2-80f1f543104b.pdf) |
| 28 January 2026 - Techera: Reg 27(2) corporate governance report not applicable for quarter ended Dec 31, 2025 (SME-listed). | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 28 January 2026 - Techera: Reg 27(2) corporate governance report not applicable for quarter ended Dec 31, 2025 (SME-listed).](https://nsearchives.nseindia.com/corporate/TECHERA_28012026082616_NSE_Non-applicability_of_Corporate_Governance_report.pdf) |
| 21 December 2025 - Investor factory visit scheduled December 24, 2025 at TechEra Engineering’s Velu (Bhor) facility. | [Analysts/Institutional Investor Meet/Con. Call Updates 21 December 2025 - Investor factory visit scheduled December 24, 2025 at TechEra Engineering’s Velu (Bhor) facility.](https://nsearchives.nseindia.com/corporate/TECHERA_21122025181743_Techera_Intimation.pdf) |
| 20 Mar - Mr. Jesús Diaz-Ropero Esteso resigned as Non-Executive Director, effective March 19, 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 20 Mar - Mr. Jesús Diaz-Ropero Esteso resigned as Non-Executive Director, effective March 19, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7cf8ba32-b152-454b-9182-03aa9b7e0b88.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28878_TECHERA_2024_2025_A_11495652_07092025165331.pdf) |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_829_ASTRAZEN_2012_2013_30072013174501.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0bd676e5-6b94-45bc-83d8-e599c9165621.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08c2022f-1184-41e7-839c-bf4352a3e535.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75c0cbf9-4e30-46d6-92f8-cf430e0ec2cc.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f65f0cd-5c2b-4b83-b480-de84bf5d341a.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/73732506820.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/68949506820.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/5068200320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506820/5068200319.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/TECHERA_15112025165823_TechEra_Transcript_of_Earning_Call.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/TECHERA_30052025153801_TechEra_Investor_Call_Transcript.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://nsearchives.nseindia.com/corporate/TECHERA_07022025182958_NSE_Transcript_of_Investor_call.pdf) |
| Dec 2025 | [Concall - Dec 2025](https://nsearchives.nseindia.com/corporate/TECHERA_19122025174018_TechEra_Investor_Call_Transcript_17-12-2025.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:29.105Z.